ARWR logo

ARWR

Profile

Full Name

Arrowhead Pharmaceuticals, Inc.

Ticker Symbol

ARWR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 16, 1993

Indexes

Not included

Website

http://arrowheadpharma.com

Employees

609

Key Details

Price

$13.34(+2.54%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.55M(-98.52% YoY)

Annual EPS

-$5.00(-160.42% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.34
ARWR price is $13.34

30-Day Relative Volume

0.51
ARWR 30-day relative volume is 0.51

Price Performance

Price Most recent change

+2.54%
ARWR price was up +2.54% on Apr 24, 2025

Price YTD change

-29.04%
ARWR price is down -29.04% since January 1st

Price 1-year change

-42.72%
ARWR price is down -42.72% year-on-year

Price 3-year change

-68.73%
ARWR price is down -68.73% over the past 3 years

Price Range

Price All-time high

$2925.00
ARWR price is currently -99.54% below its historical high of $2925.00

Price 3-year low

$9.57
ARWR price is currently +39.39% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.68B
ARWR market capitalization is $1.68 billion

Market cap 3-year change

-62.7%
ARWR market capitalization is down -62.7% over the past 3 years

Market cap All-time high

$9.40B
ARWR market capitalization is currently -82.11% below its historical high of $9.40 billion

Market cap sector rank

81.03%
ARWR market capitalization is higher than 81.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.58%
ARWR shares outstanding is up +1.58% year-on-year

Shares Outstanding 3-Year Change

+19.3%
ARWR shares outstanding is up +19.3% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.61
ARWR beta is 1.61

200-day SMA

$20.22
ARWR price is currently -34.04% below its 200-day simple moving average

50-day SMA

$15.21
ARWR price is currently -12.30% below its 50-day simple moving average

RSI

51.42
ARWR 14-day relative strength index is 51.42

Volume

0.51
ARWR 30-day relative volume is 0.51

ATR

$0.96
ARWR average true range is $0.96

10-day Historical Volatility

95.81%
ARWR 10-day historical volatility is 95.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.55M
ARWR annual revenue is $3.55 million

Revenue Analysts estimate

$320.74M
ARWR annual revenue is currently -98.89% lower than the consensus analysts' forecast

Revenue 1-year change

-98.52%
ARWR annual revenue is down -98.52% year-on-year

Revenue Sector rank

19.45%
ARWR annual revenue is higher than 19.45% of companies in Healthcare sector

EPS

EPS

-$5.00
ARWR annual earnings per share is -$5.00

EPS Analysts estimate

-$3.32
ARWR annual earnings per share is currently +50.72% higher than the consensus analysts' forecast

EPS 1-year change

-160.42%
ARWR annual earnings per share is down -160.42% year-on-year

EPS Sector rank

18.86%
ARWR annual earnings per share is higher than 18.86% of companies in Healthcare sector

Profit

Gross profit

-
ARWR annual gross profit value is unknown

Gross margin

-
ARWR annual gross profit margin value is unknown

Operating profit

-$601.08M
ARWR annual operating income is -$601.08 million

Operating margin

-16.93K%
ARWR annual operating profit margin is -16.93 thousand%

Net income

-$599.49M
ARWR annual net profit is -$599.49 million

Net margin

-16.88K%
ARWR annual net profit margin is -16.88 thousand%

Expenses

Total expenses

$604.63M
ARWR annual total expenses is $604.63 million

Operating expenses

$604.63M
ARWR annual total operating expenses is $604.63 million

Cost of goods sold

-
ARWR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$96.82M
ARWR annual SGA is $96.82 million

Depreciation and amortization

$18.59M
ARWR annual depreciation & amortization is $18.59 million

Interest expense

$32.35M
ARWR annual interest expense is $32.35 million

Income tax

-$2.77M
ARWR annual income tax is -$2.77 million

EBIT & EBITDA

EBIT

-$580.11M
ARWR annual earnings before interest & taxes is -$580.11 million

EBITDA

-$561.51M
ARWR annual EBITDA is -$561.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.14B
ARWR annual total assets is $1.14 billion

Non current assets

$444.33M
ARWR annual long term assets is $444.33 million

Current assets

$695.47M
ARWR annual total current assets is $695.47 million

Cash and cash equivalents

$102.69M
ARWR annual cash & cash equivalents is $102.69 million

Accounts receivable

-
ARWR annual accounts receivable value is unknown

Inventory

-
ARWR annual inventory value is unknown

Liabilities

Total liabilities

$948.74M
ARWR annual total liabilities is $948.74 million

Long term liabilities

$845.57M
ARWR annual total long term liabilities is $845.57 million

Current liabilities

$103.17M
ARWR annual total current liabilities is $103.17 million

Accounts payable

$11.39M
ARWR annual accounts payable is $11.39 million

Debt

Total debt

$510.55M
ARWR annual total debt is $510.55 million

Total debt 1-year change

+343.3%
ARWR annual total debt is up +343.3% year-on-year

Long term debt

$504.21M
ARWR annual long term debt is $504.21 million

Short term debt

$6.34M
ARWR annual short term debt is $6.34 million

Equity & Capital

Shareholders equity

$185.44M
ARWR annual stockholders equity is $185.44 million

Book value

$185.44M
ARWR annual book value is $185.44 million

Retained earnings

-$1.63B
ARWR annual retained earnings is -$1.63 billion

Working capital

$592.30M
ARWR annual working capital is $592.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$462.85M
ARWR annual cash flow from operations is -$462.85 million

Cash from operations 1-year change

-200.77%
ARWR annual cash flow from operations is down -200.77% year-on-year

Cash from investing

-$420.07M
ARWR annual cash flow from investing activities is -$420.07 million

Cash from investing 1-year change

-336.87%
ARWR annual cash flow from investing activities is down -336.87% year-on-year

Cash from financing

$870.52M
ARWR annual cash flow from financing activities is $870.52 million

Cash from financing 1-year change

+244.01%
ARWR annual cash flow from financing activities is up +244.01% year-on-year

CAPEX

CAPEX

$141.47M
ARWR annual capital expenditures is $141.47 million

CAPEX 1-year change

-19.96%
ARWR annual capital expenditures is down -19.96% year-on-year

Free Cash Flow

Free cash flow

-$604.32M
ARWR annual free cash flow is -$604.32 million

Free cash flow 1-year change

-82.78%
ARWR annual free cash flow is down -82.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ARWR annual gross profit margin value is unknown

Operating margin

-16.93K%
ARWR annual operating profit margin is -16.93 thousand%

Net margin

-16.88K%
ARWR annual net profit margin is -16.88 thousand%

ROA & ROE

ROA

-62.93%
ARWR annual return on assets is -62.93%

ROE

-250.72%
ARWR annual return on equity is -250.72%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARWR price to earnings ratio value is unknown

PE ratio Sector rank

-
ARWR price to earnings ratio is unknown

PB Ratio

PB ratio

31.99
ARWR price to book ratio is 31.99

PB ratio Sector rank

97.43%
ARWR price to book ratio is higher than 97.43% of companies in Healthcare sector

PS Ratio

PS ratio

672.86
ARWR price to sales ratio is 672.86

PS ratio Sector rank

97.92%
ARWR price to sales ratio is higher than 97.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.15B
ARWR enterprise value is $2.15 billion

Enterprise value Sector rank

82.65%
ARWR enterprise value is higher than 82.65% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.71
ARWR EV/EBITDA is -3.71

EV/EBITDA Sector rank

24.8%
ARWR EV/EBITDA is higher than 24.8% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.74
ARWR annual current ratio is 6.74

Quick ratio

-
ARWR annual quick ratio value is unknown

Leverage

Debt to equity

2.12
ARWR annual debt to equity ratio is 2.12

Interest coverage ratio

-17.93
ARWR annual interest coverage ratio is -17.93

Risk & Stability

Piotroski F-Score

-
ARWR piotroski f-score value is unknown

Altman Z-Score

-1.99
ARWR altman z-score is -1.99

Analyst ratings

Recent major analysts updates

Feb 14, 25 B. Riley Securities
Buy
Feb 12, 25 HC Wainwright & Co.
Buy
Feb 11, 25 RBC Capital
Outperform
Feb 11, 25 Chardan Capital
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 29, 24 Bernstein
Market Perform

Institutional Ownership

Similar stocks

HRMY logo
Harmony Biosciences Holdings (HRMY)
AGIO logo
Agios Pharmaceuticals (AGIO)
BEAM logo
Beam Therapeutics (BEAM)
IDYA logo
IDEAYA Biosciences (IDYA)
ATRC logo
AtriCure (ATRC)
BCRX logo
BioCryst Pharmaceuticals (BCRX)
ATEC logo
Alphatec Holdings (ATEC)
CGON logo
CG Oncology (CGON)
GLPG logo
Galapagos NV (GLPG)
  • What is the ticker symbol for Arrowhead Pharmaceuticals?
  • Does Arrowhead Pharmaceuticals pay dividends?
  • What sector is Arrowhead Pharmaceuticals in?
  • What industry is Arrowhead Pharmaceuticals in?
  • What country is Arrowhead Pharmaceuticals based in?
  • When did Arrowhead Pharmaceuticals go public?
  • Is Arrowhead Pharmaceuticals in the S&P 500?
  • Is Arrowhead Pharmaceuticals in the NASDAQ 100?
  • Is Arrowhead Pharmaceuticals in the Dow Jones?
  • When was Arrowhead Pharmaceuticals's last earnings report?
  • When does Arrowhead Pharmaceuticals report earnings?
  • Should I buy Arrowhead Pharmaceuticals stock now?

What is the ticker symbol for Arrowhead Pharmaceuticals?

The ticker symbol for Arrowhead Pharmaceuticals is NASDAQ:ARWR

Does Arrowhead Pharmaceuticals pay dividends?

No, Arrowhead Pharmaceuticals does not pay dividends

What sector is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Healthcare sector

What industry is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Biotechnology industry

What country is Arrowhead Pharmaceuticals based in?

Arrowhead Pharmaceuticals is headquartered in United States

When did Arrowhead Pharmaceuticals go public?

Arrowhead Pharmaceuticals's initial public offering (IPO) was on December 16, 1993

Is Arrowhead Pharmaceuticals in the S&P 500?

No, Arrowhead Pharmaceuticals is not included in the S&P 500 index

Is Arrowhead Pharmaceuticals in the NASDAQ 100?

No, Arrowhead Pharmaceuticals is not included in the NASDAQ 100 index

Is Arrowhead Pharmaceuticals in the Dow Jones?

No, Arrowhead Pharmaceuticals is not included in the Dow Jones index

When was Arrowhead Pharmaceuticals's last earnings report?

Arrowhead Pharmaceuticals's most recent earnings report was on Feb 10, 2025

When does Arrowhead Pharmaceuticals report earnings?

The next expected earnings date for Arrowhead Pharmaceuticals is May 9, 2025

Should I buy Arrowhead Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page